Intrauterine growth retardation and long-term effects on growth

D Botero1, F Lifshitz

  • 1Miami Children's Hospital, Department of Medical Education, Florida 33155, USA.

Insights

Intrauterine growth retardation (IUGR) leads to significant health issues and growth disabilities. Recent studies explore human growth hormone and genetic factors to improve outcomes for affected children.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Intrauterine growth retardation (IUGR) is a prevalent condition associated with significant morbidity and mortality.
  • Long-term growth disabilities are a critical sequela of IUGR, impacting final height potential.
  • Emerging evidence links IUGR causes to adult-onset disorders.

Purpose of the Study:

  • To review the impact of intrauterine growth retardation (IUGR) on child development.
  • To evaluate recent trials using human growth hormone for IUGR management.
  • To discuss advances in fetal growth, genetics, and endocrine factors related to IUGR.

Main Methods:

  • Review of recent clinical trials involving human growth hormone therapy in IUGR patients.
  • Analysis of epidemiological and clinical data on IUGR causes.
  • Examination of genetic and endocrine factors influencing fetal growth.

Main Results:

  • Human growth hormone therapy shows potential in maximizing growth and final height in children with IUGR.
  • Recent advances in understanding genetic and endocrine factors are crucial for fetal growth.
  • IUGR etiology is increasingly linked to adult-onset conditions.

Conclusions:

  • Intrauterine growth retardation (IUGR) requires comprehensive management strategies focusing on long-term growth.
  • Human growth hormone offers a promising therapeutic avenue for improving growth outcomes.
  • Further research into IUGR's origins and long-term health implications is essential.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...